IBIO vs ENTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

IBIO

45.7
AI Score
VS
IBIO Wins

ENTX

40.7
AI Score

Investment Advisor Scores

IBIO

46score
Recommendation
HOLD

ENTX

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO ENTX Winner
Net Income -7.55M -26.41M IBIO
Operating Income -8.34M -15.37M IBIO
ROE -9.6% -9.6% ENTX
ROA -8.5% -9.5% IBIO
Total Assets 88.65M 277.04M ENTX
Cash 45.44M 265.88M ENTX
Current Ratio 9.48 128.41 ENTX
Free Cash Flow -9.49M -13.98M IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -2.4% · 3M: -46.7% ENTX 1M: +28.8% · 3M: +11.4%

Current Technical Phase

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -20.3%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $0.76

ENTX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.2 · Price: $3.22

Fundamentals Snapshot

Metric IBIO ENTX
Market Cap — —
Forward P/E -2.5 -7.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -1.0% -1.0%
Gross Margin 1.0% —
Operating Margin -301.4% 0.0%
EPS -0.27 -0.40
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.